CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −155 | $180.01 | $28K | 45,147 |
| 2025-10-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −92 | $181.18 | $17K | 45,055 |
| 2025-09-23 | Aryeh Jason Director | Sale | −4,418 | $170.41 | $753K | 74,871 |
| 2025-09-23 | Aryeh Jason Director | Sale | −4,628 | $170.96 | $791K | 70,243 |
| 2025-09-23 | Aryeh Jason Director | Sale | −954 | $171.92 | $164K | 69,289 |
| 2025-09-22 | Zimmermann Martine Director | Shares withheld for taxes | −115 | $170.77 | $20K | 4,443 |
| 2025-09-02 | KOZARICH JOHN W Director | Sale 10b5-1 | −267 | $161.51 | $43K | 45,722 |
| 2025-09-02 | KOZARICH JOHN W Director | Sale 10b5-1 | −115 | $162.52 | $19K | 45,607 |
| 2025-09-02 | KOZARICH JOHN W Director | Sale 10b5-1 | −85 | $164.25 | $14K | 45,522 |
| 2025-08-10 | Reardon Andrew CLO & Secretary | Shares withheld for taxes | −1,325 | $150.06 | $199K | 30,811 |
| 2025-08-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −467 | $131.88 | $62K | 45,989 |
| 2025-07-10 | KOZARICH JOHN W Director | Sale 10b5-1 | −934 | $125.00 | $117K | 46,456 |
| 2025-06-30 | Reardon Andrew CLO & Secretary | Other acquisition | +233 | $91.08 | $21K | 32,136 |
| 2025-06-30 | Espinoza Octavio Chief Financial Officer | Other acquisition | +224 | $91.08 | $20K | 29,852 |
| 2025-06-30 | Davis Todd C Chief Executive Officer | Other acquisition | +233 | $91.08 | $21K | 161,467 |
| 2025-06-23 | Reardon Andrew CLO & Secretary | Sale | −500 | $114.08 | $57K | 31,903 |
| 2025-06-10 | Reardon Andrew CLO & Secretary | Sale | −500 | $114.54 | $57K | 32,403 |
| 2025-06-06 | Gray Nancy Ryan Director | Grant or award | +1,209 | 8,094 | ||
| 2025-06-06 | Gray Nancy Ryan Director | Grant or award · Non-Qualified Stock Option (right to buy) | +5,783 | 5,783 | ||
| 2025-06-06 | Aryeh Jason Director | Grant or award | +1,209 | 79,289 |
Page 15 of 43 · 858 trades